The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Adenovirus-Mediated Transfer of the CFTR Gene to Lung of Nonhuman Primates: Toxicity Study
Open accessAbstract
In preparation for human trials of gene therapy for cystic fibrosis (CF), we performed a preclinical study of gene transfer into the lungs of baboons. Recombinant adenovirus vectors containing expression cassettes for human cystic fibrosis transmembrane conductance regulator (CFTR) and Escherichia coli β-galactosidase (lacZ) were instilled through a bronchoscope into limited regions of lung in 14 baboons. A detailed accounting of the extent, distribution, and duration of gene expression is contained in a companion article (Engelhardt et al., 1993b). In this article, we report the results of toxicity studies in which clinical laboratory tests, chest radiographs, and necropsy studies were used to detect adverse effects. The only adverse effect noted was a mononuclear cell inflammatory response within the alveolar compartment of animals receiving doses of virus that were required to induce detectable gene expression. Minimal inflammation was seen at 107 and 108 pfu/ml, but at 109 and more prominently at 1010 pfu/ml, a perivascular lymphocytic and histocytic infiltrate was seen. The intensity of inflammation increased between 4 and 21 days. At its greatest intensity, there was diffuse alveolar wall damage with intra-alveolar edema. Airways were relatively spared, despite the intensity of alveolar inflammation. Clinical tests did not accurately reflect the presence of lung inflammation, with the exception of chest radiographs which revealed alveolar infiltrates, but only in regions of lung having the greatest intensity inflammation. We conclude that adenovirus-mediated gene transfer into the lungs of baboons is associated with development of alveolar inflammation at high doses of virus. Experiments in small animals support the feasibility of recombinant adenoviruses for treating CF lung disease. Studies in nonhuman primates are critical in assessing the potential toxicities associated with these therapies. In a series of two papers, Wilson and colleagues have simulated the general construct of a phase I trial in baboons to evaluate the feasibility and safety of recombinant adenoviruses for gene therapy of CF lung disease. This paper by Simon et al., evaluates the clinical and pathological consequences of direct instillation of CFTR expressing adenoviruses in the airway of baboons.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosenfeld, M. A., Yoshimura, K., Trapnell, B. C., Yoneyama, K., Rosenthal, E. R., Dalemans, W., Fukayama, M., Bargon, J., Stier, L. E., Stratford-Perricaudet, L., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90213-v · Cited by 931
Crystal, R. G., McElvaney, N. G., Rosenfeld, M. A., Chu, C.-S., Mastrangeli, A., Hay, J. G., Brody, S. L., Jaffe, H. A., Eissa, N. T., & Danel, C. (1994) · Nature Genetics · doi:10.1038/ng0994-42 · Cited by 826
Adenovirus-Mediated Transfer of a Recombinant α1-Antitrypsin Gene to the Lung Epithelium in Vivo
Rosenfeld, M. A., Siegfried, W., Yoshimura, K., Yoneyama, K., Fukayama, M., Stier, L. E., Pääkkö, P. K., Gilardi, P., Stratford-Perricaudet, L. D., Perricaudet, M., et al. (1991) · Science · doi:10.1126/science.2017680 · Cited by 737
Yang, Y., Nunes, F. A., Berencsi, K., Gönczöl, E., Engelhardt, J. F., & Wilson, J. M. (1994) · Nature Genetics · doi:10.1038/ng0794-362 · Cited by 450
Self-citationEngelhardt, J. F., Yang, Y., Stratford-Perricaudet, L. D., Allen, E. D., Kozarsky, K., Perricaudet, M., Yankaskas, J. R., & Wilson, J. M. (1993) · Nature Genetics · doi:10.1038/ng0593-27 · Cited by 294
Self-citationEngelhardt, J. F., Simon, R. H., Yang, Y., Zepeda, M., Weber-Pendleton, S., Doranz, B., Grossman, M., & Wilson, J. M. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.6-759 · Cited by 195
Self-citationSchaefer, H. E. (1983) · Current topics in pathology · doi:10.1007/978-3-642-69134-8_4 · Cited by 20
Cited by
Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.
Yang, Y., Nunes, F. A., Berencsi, K., Furth, E. E., Gönczöl, E., & Wilson, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4407 · Cited by 1,575
Self-citationHuman β-Defensin-1 Is a Salt-Sensitive Antibiotic in Lung That Is Inactivated in Cystic Fibrosis
Goldman, M. J., Anderson, G. M., Stolzenberg, E. D., Kari, U. P., Zasloff, M., & Wilson, J. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81895-4 · Cited by 1,080
Self-citationCrystal, R. G., McElvaney, N. G., Rosenfeld, M. A., Chu, C.-S., Mastrangeli, A., Hay, J. G., Brody, S. L., Jaffe, H. A., Eissa, N. T., & Danel, C. (1994) · Nature Genetics · doi:10.1038/ng0994-42 · Cited by 826
Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy
Mittereder, N., March, K. L., & Trapnell, B. C. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.7498-7509.1996 · Cited by 777
Tripathy, S. K., Black, H. B., Goldwasser, E., & Leiden, J. M. (1996) · Nature Medicine · doi:10.1038/nm0596-545 · Cited by 628
Yang, Y., Ertl, H. C. J., & Wilson, J. M. (1994) · Immunity · doi:10.1016/1074-7613(94)90074-4 · Cited by 611
Self-citationDai, Y., Schwarz, E. M., Gu, D., Zhang, W. W., Sarvetnick, N., & Verma, I. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1401 · Cited by 591
Knowles, M. R., Hohneker, K. W., Zhou, Z., Olsen, J. C., Noah, T. L., Hu, P.-C., Leigh, M. W., Engelhardt, J. F., Edwards, L. J., Jones, K. R., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331302 · Cited by 566
Self-citationRiddell, S. R., Elliott, M., Lewinsohn, D. A., Gilbert, M. J., Wilson, L., Manley, S. A., Lupton, S. D., Overell, R. W., Reynolds, T. C., Corey, L., et al. (1996) · Nature Medicine · doi:10.1038/nm0296-216 · Cited by 565
Kochanek, S., Clemens, P. R., Mitani, K., Chen, H. H., Chan, S., & Caskey, C. T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5731 · Cited by 562
Borchard, G. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00198-3 · Cited by 534
Nemunaitis, J., Khuri, F., Ganly, I., Arseneau, J., Posner, M., Vokes, E., Kuhn, J., McCarty, T., Landers, S., Blackburn, A., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.289 · Cited by 471
Yang, Y., Nunes, F. A., Berencsi, K., Gönczöl, E., Engelhardt, J. F., & Wilson, J. M. (1994) · Nature Genetics · doi:10.1038/ng0794-362 · Cited by 450
Self-citationChang, M. W., Barr, E., Seltzer, J., Jiang, Y.-Q., Nabel, G. J., Nabel, E. G., Parmacek, M. S., & Leiden, J. M. (1995) · Science · doi:10.1126/science.7824950 · Cited by 446
Gene Therapy for Vascular Smooth Muscle Cell Proliferation After Arterial Injury
Ohno, T., Gordon, D., San, H., Pompili, V. J., Imperiale, M. J., Nabel, G. J., & Nabel, E. G. (1994) · Science · doi:10.1126/science.8047883 · Cited by 433
O'Riordan, C. R., Lachapelle, A., Delgado, C., Parkes, V., Wadsworth, S. C., Smith, A. E., & Francis, G. E. (1999) · Human Gene Therapy · doi:10.1089/10430349950018021 · Cited by 409
ROLE OF ENDOTHELIUM IN THROMBOSIS AND HEMOSTASIS
Wu, M. D., & Thiagarajan, M. D. (1996) · Annual Review of Medicine · doi:10.1146/annurev.med.47.1.315 · Cited by 384
Grubb, B. R., Pickles, R. J., Ye, H., Yankaskas, J. R., Vick, R. N., Engelhardt, J. F., Wilson, J. M., Johnson, L. G., & Boucher, R. C. (1994) · Nature · doi:10.1038/371802a0 · Cited by 365
Self-citationNemunaitis, J., Swisher, S. G., Timmons, T., Connors, D., Mack, M., Doerksen, L., Weill, D., Wait, J., Lawrence, D. D., Kemp, B. L., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.3.609 · Cited by 322
Zabner, J., Ramsey, B. W., Meeker, D. P., Aitken, M. L., Balfour, R. P., Gibson, R. L., Launspach, J., Moscicki, R. A., Richards, S. M., & Standaert, T. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118573 · Cited by 265
In vivo model of adeno-associated virus vector persistence and rescue
Afione, S. A., Conrad, C. K., Kearns, W. G., Chunduru, S., Adams, R., Reynolds, T. C., Guggino, W. B., Cutting, G. R., Carter, B. J., & Flotte, T. R. (1996) · Journal of Virology · doi:10.1128/jvi.70.5.3235-3241.1996 · Cited by 223
“In vivo gene transfer has been observed with Ad vectors in the airways of cotton rats (17, 18) and nonhuman primates (5, 23).”
BackgroundGorziglia, M. I., Kadan, M. J., Yei, S., Lim, J., Lee, G. M., Luthra, R., & Trapnell, B. C. (1996) · Journal of Virology · doi:10.1128/jvi.70.6.4173-4178.1996 · Cited by 193
Favre, D., Provost, N., Blouin, V., Blancho, G., Chérel, Y., Salvetti, A., & Moullier, P. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0494 · Cited by 122
(1997) · PubMed · Cited by 105
Lipid Nanoparticles for Ocular Gene Delivery
Wang, Y., Rajala, A., & Rajala, R. (2015) · Journal of Functional Biomaterials · doi:10.3390/jfb6020379 · Cited by 93
“adeno-associated virus (AAV), have attractive features, particularly their high gene transduction capability, they face biosafety issues, especially innate and immune barriers [27], toxicity [28], and potential recombination of or complementation [29] to vector delivery.”
BackgroundWilmott, R. W., Amin, R. S., Perez, C. R., Wert, S. E., Keller, G., Boivin, G. P., Hirsch, R., de Inocencio, J., Lu, P., Reising, S. F., et al. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.3-301 · Cited by 63
Genetic Modification of the Lung Directed Toward Treatment of Human Disease
Sondhi, D., Stiles, K. M., De, B. P., & Crystal, R. G. (2017) · Human Gene Therapy · doi:10.1089/hum.2016.152 · Cited by 36
Metadata
- Authors
- Simon, R. H., Engelhardt, J. F., Yang, Y., Zepeda, M., Weber-Pendleton, S., Grossman, M., & Wilson, J. M.
- Venue
- Human Gene Therapy
- Publisher
- SAGE Publications
- Published
- 1993-12
- Volume
- 4
- Issue
- 6
- Pages
- 771-780
- ISSN
- 1043-0342 (ISSN-L)
- 1557-7422
- OpenAlex
- W1999157369
- Cited by
- 323
- References
- 7
- FWCI
- 19.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.